Pharmacological and genetic modifications of somatic cholesterol do not substantially alter the course of CNS disease in Niemann-Pick C mice

Journal of Inherited Metabolic Disease

Volumn 23, Issue 1, 2000, Pages 54-62

  Erickson, R P ^a   Garver, W S ^a   Camargo, F ^a   Hossain, G S ^a   Heidenreich, R A ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; NIFEDIPINE; PROBUCOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CHOLESTEROL LIVER LEVEL; DISEASE COURSE; DNA MODIFICATION; GENE MUTATION; KNOCKOUT MOUSE; MOUSE; NIEMANN PICK DISEASE; NONHUMAN;

ANIMALS; BLOOD-BRAIN BARRIER; CHOLESTEROL; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; NIEMANN-PICK DISEASES; NIFEDIPINE; PROBUCOL; RECEPTORS, LDL;

EID: 0033959686     PISSN: 01418955     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005650930330     Document Type: Article

References (23)

1. Carstea ED, Morris JA, Coleman KG, et al (1997) Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis. Science 277: 228-231.
2. Chisolm GM III, Morel DW (1988) Lipoprotein oxidation and cytotoxicity: effect of probucol on streptozotocin-treated rats. Am J Cardiol 62: 20B-26B.
3. Dushkin MI, Schwartz YSh (1995) Effect of verapamil and nifedipine on cholesteryl ester metabolism and low density lipoprotein oxidation in macrophages. Biochem Pharmacol 49: 389-397.
4. Erickson RP, Aviles RA, Zhang J, Kozloski MA, Garver WS, Heidenreich RA (1997) High-resolution mapping of the spm (Niemann-Pick type C) locus on mouse chromosome 18. Mamm Genome 8: 355-356.
5. Frykman PK, Brown MS, Yamamoto T, Goldstein JL, Herz J (1995) Normal plasma lipoproteins and fertility in gene-targeted mice homozygous for a disruption in the gene encoding very low density lipoprotein receptor. Proc Natl Acad Sci USA 92: 8453-8457.
6. Gaw A, Mancini FP, Ishibashi S (1995) Rapid genotyping of low density lipoprotein receptor knockout mice using a polymerase chain reaction technique. Lab Anim 29: 447-449.
7. Goldstein JL, Ho YK, Basu SK, Brown MS (1979) Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci USA 76: 333-337.
8. Han J, Haijjar DP, Febbraio M, Nicholson AC (1997) Native and modified low density lipoproteins increase the functional expression of the macrophage class B scavenger receptor, CD36. J Biol Chem 272: 21654-21659.
9. Heidenreich RA, Erickson RP (1997) Niemann-Pick C disease: recent advances. J Rare Dis 3: 5-19.
10. Heider JG, Boyett RL (1978) The picomole determination of free and total cholesterol in cells in culture. J Lipid Res 19: 514-518.
11. Horton JD, Bashmakov Y, Shimomura I, Shimano H (1998) Regulation of sterol regulatory element binding proteins in livers of fasted and refed mice. Proc Natl Acad Sci USA 95: 5987-5992.
12. Ishibashi S, Brown MS, Goldstein JL, Gerard RD, Hammer RE, Herz J (1993) Hyper-cholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J Clin Invest 92: 883-893.
13. Ishibashi S, Goldstein JL, Brown MS, Herz J, Burns DK (1994) Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice. J Clin Invest 93: 1885-1893.
14. Loftus SK, Morris JA, Carstea ED, et al (1997) Murine model of Niemann-Pick C disease: mutation in a cholesterol homeostasis gene. Science 277: 232-235.
15. Naruszewicz M, Carew TE, Pittman RC, Witztum JL, Steinberg D (1984) A novel mechanism by which probucol lowers low density lipoprotein levels demonstrated in the LDL receptor-deficient rabbit. J Lipid Res 25: 1206-1213.
16. Patterson MC, Di Bisceglie AM, Higgins JJ, et al (1993) The effect of cholesterol-lowering agents on hepatic and plasma cholesterol in Niemann-Pick disease type C. Neurology 43: 61-64.
17. Pentchev PC, Boothe AD, Kruth HS, Weintroub H, Stivers J, Brady RO (1984) A genetic storage disorder in BALB/c mice with a metabolic block in esterification of exogenous cholesterol. J Biol Chem 259: 5784-5791.
18. Pentchev PG, Vanier MT, Suzuki K, Patterson MC (1995) Niemann-Pick disease type C: a cellular cholesterol lipidosis. In Scriver C, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. New York: McGraw-Hill, 2625-2639.
19. Sakuragawa N, Ohmura K, Suzuki K, Miyazato T (1988) Clinical improvement with DMSO treatment in a patient with Niemann-Pick disease (type C). Acta Paediatr Japan 30: 509-516.
20. Sylvain M, Arnold DL, Scriver CR, Schreiber R, Shevell MI (1994) Magnetic resonance spectroscopy in Niemann-Pick disease type C: correlation with diagnosis and clinical response to cholestyramine and lovastatin. Pediatr Neurol 10: 228-232.
21. Thomas GH, Tuck-Muller CM, Miller CS, Reynolds LW (1989) Correction of sphingomyelinase deficiency in Niemann-Pick type C fibroblasts by removal of lipoprotein fraction from culture media. J Inher Metab Dis 12: 139-151.
22. Tint GS, Pentchev P, Xu G, et al (1998) Cholesterol and oxygenated cholesterol concentrations are markedly elevated in peripheral tissue but not in brain from mice with the Niemann-Pick type C phenotype. J Inher Metab Dis 21: 853-863.
23. Windholz M (ed.) (1976) Merck Index, 9th edn. Rahway, NJ: Merck & Co., 848 (6352).